Skip to Main Content

Author Details

David W Haas
Vanderbilt University Medical Center
1988
228
54
PMIDPaper TitleJournal TitlePublished Year
37910437Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens.Pharmacogenet Genomics2024
37910437Pharmacogenetics of weight gain following switch from efavirenz- to integrase inhibitor-containing regimens.Pharmacogenet Genomics2024
36540980Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain.Pac Symp Biocomput2023
37693472Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.medRxiv2023
37306344Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.Pharmacogenet Genomics2023
37368931Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.J Acquir Immune Defic Syndr2023
36540980Leveraging Multi-Ancestry Polygenic Risk Scores for Body Mass Index to Predict Antiretroviral Therapy-Induced Weight Gain.Pac Symp Biocomput2023
37532928Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37099271Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.Pharmacogenet Genomics2023
37098852Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV.Pharmacogenet Genomics2023
37693472Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort.medRxiv2023
37532928Africa-specific human genetic variation near CHD1L associates with HIV-1 load.Nature2023
37306344Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.Pharmacogenet Genomics2023
37368931Associations of Muscle Density and Area With Coronary Artery Plaque and Physical Function.J Acquir Immune Defic Syndr2023
37099271Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans.Pharmacogenet Genomics2023
37098852Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV.Pharmacogenet Genomics2023
34369424Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.Pharmacogenet Genomics2022
35512135Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.J Infect Dis2022
36031789Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.J Antimicrob Chemother2022
34214166A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.Clin Infect Dis2022
34369424Pharmacogenetics of interaction between depot medroxyprogesterone acetate and efavirenz, rifampicin, and isoniazid during treatment of HIV and tuberculosis.Pharmacogenet Genomics2022
35091749Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.J Infect Dis2022
35512135Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.J Infect Dis2022
36031789Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population.J Antimicrob Chemother2022
35091749Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.J Infect Dis2022
34214166A Clinical Prediction Model for Unsuccessful Pulmonary Tuberculosis Treatment Outcomes.Clin Infect Dis2022
32720695Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.Clin Infect Dis2021
33901188Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.PLoS Genet2021
34007475Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid.South Afr J HIV Med2021
33625064Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir-Containing and Tenofovir-Containing Regimens.J Acquir Immune Defic Syndr2021
34036211Transdisciplinary Perspectives on Precision Medicine.Health Equity2021
33252493Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy.AIDS2021
32815870Pharmacogenetic interactions of rifapentine plus isoniazid with efavirenz or nevirapine.Pharmacogenet Genomics2021
32909316Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping.Clin Pharmacol Ther2021
33066718<i>IFNL4</i> Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency Virus.AIDS Res Hum Retroviruses2021
32902770The Effects of Perceived Stress and Cortisol Concentration on Antiretroviral Adherence When Mediated by Psychological Flexibility Among Southern Black Men Living with HIV.AIDS Behav2021
32667979Implications of Efavirenz Pharmacogenetics When Switching From Efavirenz- to Dolutegravir-containing Antiretroviral Regimens.Clin Infect Dis2021
32720695Effects of Pregnancy and Isoniazid Preventive Therapy on Mycobacterium tuberculosis Interferon Gamma Response Assays in Women With HIV.Clin Infect Dis2021
32829410Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.Clin Infect Dis2021
34611364A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.Nat Genet2021
33625064Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir-Containing and Tenofovir-Containing Regimens.J Acquir Immune Defic Syndr2021
33901188Tissue specificity-aware TWAS (TSA-TWAS) framework identifies novel associations with metabolic, immunologic, and virologic traits in HIV-positive adults.PLoS Genet2021
34611364A high-resolution HLA reference panel capturing global population diversity enables multi-ancestry fine-mapping in HIV host response.Nat Genet2021
34036211Transdisciplinary Perspectives on Precision Medicine.Health Equity2021
34007475Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid.South Afr J HIV Med2021
33252493Mitochondrial DNA haplogroups and weight gain following switch to integrase strand transfer inhibitor-based antiretroviral therapy.AIDS2021
33066718<i>IFNL4</i> Genotype Does Not Associate with CD4 T-Cell Recovery in People Living with Human Immunodeficiency Virus.AIDS Res Hum Retroviruses2021
32829410Efavirenz Pharmacogenetics and Weight Gain Following Switch to Integrase Inhibitor-Containing Regimens.Clin Infect Dis2021
32909316Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping.Clin Pharmacol Ther2021
32902770The Effects of Perceived Stress and Cortisol Concentration on Antiretroviral Adherence When Mediated by Psychological Flexibility Among Southern Black Men Living with HIV.AIDS Behav2021
  • 1 - 50 of 456

Recommended Authors

Emory University
Career Start Year 2004
Number of shared co-authors 16
University of California san francisco
Career Start Year 2002
Number of shared co-authors 14
IRCCS-ISMETT
Career Start Year 2001
Number of shared co-authors 7
University of California San Diego
Career Start Year 2001
Number of shared co-authors 28
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 15
University of Witwatersrand
Career Start Year 2000
Number of shared co-authors 1
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2000
Number of shared co-authors 10
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 9
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 9
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 5
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 14
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Career Start Year 1995
Number of shared co-authors 6
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 13
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 9
Sacramento Medical Center, Kaiser Permanente Northern California
Career Start Year 1988
Number of shared co-authors 5
La Paz University Hospital
Career Start Year 1988
Number of shared co-authors 6
Hospital Clinico San Carlos-IdiSSC, Universidad Complutense
Career Start Year 1988
Number of shared co-authors 3
University Medical Center Utrecht
Career Start Year 1988
Number of shared co-authors 3
VA Medical Center
Career Start Year 1986
Number of shared co-authors 3
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 8
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 8
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 6
Case Western Reserve University
Career Start Year 1981
Number of shared co-authors 7
School of Public Health, university of california san diego
Career Start Year 1980
Number of shared co-authors 18
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 17
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 3
Institute for Global Health Sciences, University of California san francisco
Career Start Year 1977
Number of shared co-authors 22
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1973
Number of shared co-authors 24
University of Alabama at Birmingham
Career Start Year 1972
Number of shared co-authors 8
Wistar Institute
Career Start Year 1958
Number of shared co-authors 10

Collaborators

Vanderbilt University Medical Center
Co-authored papers 34
Center for Systems Genomics, Pennsylvania State University, University Park
Co-authored papers 33
Co-authored papers 18
Co-authored papers 16
Co-authored papers 16
Co-authored papers 15
Washington University School of Medicine
Co-authored papers 14
Co-authored papers 14
Co-authored papers 13
University of Pennsylvania
Co-authored papers 13
Ragon Institute of Mass General
Co-authored papers 12
Ecole Polytechnique Federale de Lausanne
Co-authored papers 12
Vanderbilt University Medical Center
Co-authored papers 11
Co-authored papers 11
Co-authored papers 11
Frederick National Laboratory for Cancer Research, National Cancer Institute
Co-authored papers 10
Vertex Pharmaceuticals
Co-authored papers 10
Cleveland Clinic/Lerner Research Institute
Co-authored papers 9
1 Vanderbilt University Medical Center
Co-authored papers 9
University of California san francisco
Co-authored papers 9
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 9
Vanderbilt University
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 8
Co-authored papers 7
National Institute of Environmental Health Sciences
Co-authored papers 7
Northwestern University Feinberg School of Medicine
Co-authored papers 7
Corporal Michael J Crescenz VA Medical Center Philadelphia
Co-authored papers 7
Co-authored papers 6